Physician profile
Michael D Ho
NPI 1790785517
$1,164.17
in general payments reported to CMS, 2019-2025
13 companies · $179 in 2025
The $179 reported for 2025 was more than what 79% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2021: $459 · 2022: $52.90 · 2023: $174 · 2024: $71.03 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $424.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $208.74 | 2021 | |
| Heron Therapeutics, INC. | $171.86 | 2019-2021 | |
| Edwards Lifesciences Corporation | $170.48 | 2023-2024 | |
| Mallinckrodt Enterprises LLC | $124.99 | 2019 | |
| Acacia Pharma INC | $119.83 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $92.00 | 2025 | |
| Eagle Pharmaceuticals, INC. | $74.87 | 2023 | |
| Csl Behring | $54.98 | 2025 | |
| Medtronic, INC. | $52.90 | 2022 | |
| Getinge USA Sales, LLC | $37.56 | 2019 | |
| Axsome Therapeutics, INC. | $24.55 | 2025 | Auvelity |
| Masimo Corporation | $23.81 | 2019 | |
| Neuronetics, INC. | $7.60 | 2025 | Neurostar Tms Therapy System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.